Central Trust CO Vertex Pharmaceuticals Inc Transaction History

Central Trust CO

$4 Billion
Q4 2024

A detailed history of Central Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Central Trust CO holds 9,791 shares of VRTX stock, worth $4.71 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

9,791

Previous 9,987 1.96%

Holding current value

$4.71 Million

Previous $4.64 Million 15.12%

% of portfolio

0.1%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$396.64 - $516.74 $77,741 - $101,281	-196 Reduced 1.96%	9,791 $3.94 Million
Q3 2024 Oct 22, 2024	SELL	$460.0 - $505.78 $36,800 - $40,462	-80 Reduced 0.79%	9,987 $4.64 Million
Q2 2024 Aug 05, 2024	SELL	$392.81 - $485.53 $42,423 - $52,437	-108 Reduced 1.06%	10,067 $4.72 Million
Q1 2024 Apr 24, 2024	SELL	$407.69 - $446.08 $111,707 - $122,225	-274 Reduced 2.62%	10,175 $4.25 Million
Q4 2023 Jan 24, 2024	BUY	$343.0 - $410.68 $39,445 - $47,228	115 Added 1.11%	10,449 $4.25 Million
Q3 2023 Oct 26, 2023	BUY	$338.18 - $362.46 $107,879 - $115,624	319 Added 3.19%	10,334 $3.59 Million
Q2 2023 Jul 26, 2023	BUY	$314.42 - $351.91 $199,342 - $223,110	634 Added 6.76%	10,015 $3.52 Million
Q1 2023 Apr 19, 2023	SELL	$283.23 - $323.1 $110,459 - $126,009	-390 Reduced 3.99%	9,381 $2.96 Million
Q4 2022 Jan 26, 2023	SELL	$285.76 - $321.48 $362,629 - $407,958	-1,269 Reduced 11.49%	9,771 $0
Q3 2022 Nov 17, 2022	SELL	$273.83 - $305.53 $244,530 - $272,838	-893 Reduced 7.48%	11,040 $3.2 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $176,924 - $220,290	753 Added 6.74%	11,933 $3.36 Million
Q1 2022 May 03, 2022	SELL	$221.42 - $260.97 $61,997 - $73,071	-280 Reduced 2.44%	11,180 $2.92 Million
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $531,030 - $670,350	-3,000 Reduced 20.75%	11,460 $2.52 Million
Q3 2021 Oct 19, 2021	SELL	$181.39 - $202.99 $369,310 - $413,287	-2,036 Reduced 12.34%	14,460 $2.62 Million
Q2 2021 Jul 23, 2021	SELL	$187.49 - $221.1 $345,731 - $407,708	-1,844 Reduced 10.05%	16,496 $3.33 Million
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $1.34 Million - $1.56 Million	6,459 Added 54.36%	18,340 $3.94 Million
Q4 2020 Jan 29, 2021	BUY	$207.01 - $276.09 $2.11 Million - $2.81 Million	10,185 Added 600.53%	11,881 $2.81 Million
Q3 2020 Oct 22, 2020	BUY	$255.65 - $303.1 $402,904 - $477,685	1,576 Added 1313.33%	1,696 $461,000
Q2 2020 Jul 14, 2020	SELL	$225.48 - $295.8 $7,891 - $10,353	-35 Reduced 22.58%	120 $34,000
Q1 2020 Apr 17, 2020	SELL	$199.77 - $247.81 $8,989 - $11,151	-45 Reduced 22.5%	155 $36,000
Q4 2019 Jan 21, 2020	SELL	$166.71 - $223.91 $833 - $1,119	-5 Reduced 2.44%	200 $43,000
Q2 2019 Jul 12, 2019	SELL	$164.61 - $190.37 $26,502 - $30,649	-161 Reduced 43.99%	205 $0
Q1 2019 Apr 26, 2019	BUY	$163.73 - $194.7 $13,098 - $15,576	80 Added 27.97%	366 $0
Q2 2018 Jul 09, 2018	SELL	$145.72 - $169.96 $484,810 - $565,456	-3,327 Reduced 92.08%	286 $0
Q1 2018 Apr 04, 2018	BUY	$151.6 - $177.13 $537,876 - $628,457	3,548 Added 5458.46%	3,613 $0
Q4 2017 Jan 23, 2018	SELL	$137.28 - $155.55 $7,687 - $8,710	-56 Reduced 46.28%	65 $0
Q3 2017 Oct 17, 2017	BUY	$148.13 - $162.24 $17,923 - $19,631	121	121 $0

Others Institutions Holding VRTX

# of Institutions

1,715

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account